User Tools

Site Tools


respiratory:beta2_agonists:albuterol

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision
Previous revision
respiratory:beta2_agonists:albuterol [2026/02/15 14:58] – created andrew2393cnsrespiratory:beta2_agonists:albuterol [2026/02/15 15:07] (current) – [Related] andrew2393cns
Line 1: Line 1:
 ====== Albuterol (ProAir®, Ventolin®, Proventil®) ====== ====== Albuterol (ProAir®, Ventolin®, Proventil®) ======
  
-{{tag>respiratory beta2_agonist saba bronchodilator}} +<WRAP right 340px
- +<WRAP infobox
-<WRAP right 300px+Albuterol | {{:respiratory:beta2_agonists:albuterol-teaser.png?200|}} | 
-^ Class | Short-Acting β2 Agonist (SABA) | +| Brand Names | ProAir®, Ventolin®, Proventil® | 
-^ Use Rescue inhaler +| Drug Class | [[respiratory:beta2_agonists:saba|Short-Acting β2 Agonist (SABA)]] 
-Onset | ~3–5 minutes | +Primary Indication | Acute bronchospasm 
-Duration | 4–6 hours | +| Receptor Target | β2 adrenergic receptor | 
-Route | Inhaled (MDI, DPI, Neb) |+| Mechanism | ↑ cAMP → Bronchodilation | 
 +Onset | ~3–5 minutes | 
 +Duration | 4–6 hours | 
 +Route | Inhaled (MDI, DPI, Neb) 
 +| Potassium Effect | ↓ Serum K⁺ (cellular shift) | 
 +| FDA Approval | 1981 |
 </WRAP> </WRAP>
 +</WRAP>
 +
 +===== Overview =====
 +
 +Albuterol is the first-line rescue bronchodilator for acute bronchospasm in asthma and COPD.
 +
 +It provides rapid airway smooth muscle relaxation but does **not treat airway inflammation**, making it a symptom reliever rather than a controller medication.
  
-Albuterol is the **first-line rescue bronchodilator** for acute bronchospasm in asthma and COPD.+Frequent use indicates poorly controlled disease and need for anti-inflammatory therapy such as [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]].
  
-It rapidly relaxes airway smooth muscle but **does NOT treat inflammation**.+<WRAP clear></WRAP>
  
 ---- ----
Line 19: Line 31:
 ===== Mechanism of Action ===== ===== Mechanism of Action =====
  
-β2 receptor stimulation → ↑ cAMP → bronchial smooth muscle relaxation+**Receptor Activated** 
 +  * β2 adrenergic receptor  
  
-Additional effects: +**Cellular Effects** 
-  * ↓ mast cell mediator release+  * ↑ cAMP 
 +  * Smooth muscle relaxation 
 +  * ↓ mediator release from mast cells
   * ↑ mucociliary clearance   * ↑ mucociliary clearance
-  * Drives potassium into cells (↓ serum K⁺)+ 
 +**Systemic Effect** 
 +  * Drives potassium intracellularly 
 + 
 +Net effect: 
 +  * Rapid bronchodilation and relief of airflow obstruction
  
 ---- ----
Line 33: Line 53:
   * Exercise-induced bronchospasm prevention   * Exercise-induced bronchospasm prevention
   * COPD rescue therapy   * COPD rescue therapy
-  * Hyperkalemia (temporary potassium shift)+  * Temporary treatment of hyperkalemia 
 + 
 +Often used with: 
 +  * [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]] 
 +  * [[respiratory:antimuscarinics:start|Antimuscarinics]]
  
 ---- ----
  
-===== Dosing (Typical Adult) =====+<WRAP contra> 
 +===== Contraindications =====
  
-**MDI:** 1–2 puffs every 4–6 hours PRN   +Absolute
-**Nebulizer:** 2.5 mg every 4–6 hours PRN   +  * Hypersensitivity to albuterol
-**Exercise prevention:*2 puffs 15 minutes before activity+
  
-Frequent use (>2 days/week) → indicates uncontrolled asthma+Relative Caution: 
 +  * Tachyarrhythmias 
 +  * Ischemic heart disease 
 +  * Hyperthyroidism 
 + 
 +</WRAP>
  
 ---- ----
  
-===== Adverse Effects =====+<WRAP details> 
 +===== Dosing =====
  
-^ Effect ^ Why It Happens ^ +Metered-Dose Inhaler: 
-| Tremor | βstimulation in skeletal muscle | +  * 1–puffs every 4–6 hours PRN
-| Tachycardia | β1 spillover & reflex response | +
-| Palpitations | Adrenergic stimulation | +
-| Hypokalemia | Intracellular potassium shift | +
-| Anxiety | CNS adrenergic activation |+
  
-Dose dependent.+Nebulizer: 
 +  * 2.5 mg every 4–6 hours PRN 
 + 
 +Exercise prevention: 
 +  * 2 puffs 15 minutes prior to activity 
 + 
 +Frequent use (>2 days/week): 
 +  * Indicates uncontrolled asthma 
 + 
 +</WRAP>
  
 ---- ----
  
-===== Contraindications & Cautions =====+<WRAP details> 
 +===== Pharmacokinetics =====
  
-  * Severe tachyarrhythmias +Onset: 
-  * Hyperthyroidism +  * 3–5 minutes
-  * Caution in ischemic heart disease+
  
-Not a steroid — safe in pregnancy and pediatrics.+Peak: 
 +  * ~30 minutes 
 + 
 +Duration: 
 +  * 4–6 hours 
 + 
 +Elimination: 
 +  * Hepatic metabolism and renal excretion 
 + 
 +</WRAP>
  
 ---- ----
  
-===== Clinical Pearls =====+<WRAP details> 
 +===== Adverse Effects ===== 
 + 
 +Adrenergic: 
 +  * Tremor 
 +  * Tachycardia 
 +  * Palpitations 
 +  * Anxiety 
 + 
 +Metabolic: 
 +  * Hypokalemia 
 +  * Hyperglycemia (mild) 
 + 
 +Other: 
 +  * Headache 
 + 
 +Dose dependent — more common with frequent use.
  
-<WRAP round tip 90%> 
-Using albuterol frequently does NOT mean the patient needs more albuterol   
-It means they need anti-inflammatory therapy (ICS) 
 </WRAP> </WRAP>
  
-  * First drug given in asthma exacerbation +---- 
-  * Spacer improves lung deposition significantly + 
-  * Nebulizer does NOT deliver more drug — only easier for severe distress +<WRAP details> 
-  * Causes temporary improvement in hyperkalemia+===== Drug Interactions ===== 
 + 
 +Beta-blockers: 
 +  * Reduced bronchodilator effect 
 + 
 +MAO inhibitors / stimulants: 
 +  * Increased tachycardia 
 + 
 +Diuretics: 
 +  * Increased hypokalemia risk 
 + 
 +</WRAP>
  
 ---- ----
  
 +<WRAP monitoring>
 ===== Monitoring ===== ===== Monitoring =====
  
-  * Symptom frequency +  * Rescue inhaler use frequency 
-  * Rescue inhaler use per week +  * Symptom control 
-  * Heart rate in high-dose therapy+  * Heart rate (high doses)
   * Potassium (continuous nebs)   * Potassium (continuous nebs)
 +
 +</WRAP>
 +
 +----
 +
 +<WRAP pearls>
 +===== Clinical Pearls =====
 +
 +  * First drug used in asthma exacerbation
 +  * Frequent use = need controller therapy
 +  * Spacer significantly improves lung delivery
 +  * Nebulizer easier to inhale — not stronger
 +  * Useful temporary treatment for hyperkalemia
 +
 +</WRAP>
 +
 +----
 +
 +===== Comparison Within Class =====
 +
 +Compared to [[respiratory:beta2_agonists:levalbuterol|Levalbuterol]]:
 +  * Less selective β2 activity
 +  * More tremor/tachycardia
 +  * Lower cost
 +
 +Compared to [[respiratory:beta2_agonists:formoterol|Formoterol]]:
 +  * Shorter duration
 +  * Used for rescue rather than maintenance
  
 ---- ----
  
-===== Related Drugs =====+===== Related =====
  
-  * [[respiratory:beta2_agonists:levalbuterol|Levalbuterol]] +  * [[respiratory:beta2_agonists|β2 Agonists]] 
-  * [[respiratory:beta2_agonists:formoterol|Formoterol]] +  * [[respiratory:inhaled_corticosteroids:start|Inhaled Corticosteroids]] 
-  * [[respiratory:inhaled_corticosteroids|Inhaled Corticosteroids]]+  * [[respiratory:asthma|Asthma]] 
 +  * [[respiratory:copd|COPD]]
respiratory/beta2_agonists/albuterol.1771167490.txt.gz · Last modified: by andrew2393cns